Equities
  • Price (EUR)294.70
  • Today's Change-8.00 / -2.64%
  • Shares traded0.00
  • 1 Year change-39.86%
  • Beta0.6100
Data delayed at least 15 minutes, as of Jul 04 2025.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

  • Revenue in USD (TTM)183.12bn
  • Net income in USD5.92bn
  • Incorporated2001
  • Employees103.16k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ELV:NYQ since
announced
Transaction
value
Granular Insurance Co IncAnnounced06 Feb 202506 Feb 2025Announced-13.51%--
Centers Plan for Healthy Living LLCDeal completed31 Dec 202431 Dec 2024Deal completed-5.68%--
RSV QOZB LTSS IncAnnounced17 Oct 202417 Oct 2024Announced-30.01%--
Indiana University Health Inc-Insurance BusinessAnnounced10 Sep 202410 Sep 2024Announced-36.02%--
Data delayed at least 15 minutes, as of Jul 03 2025 18:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.